A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome
NCT05153434
Abnormalities, Multiple, Chromosome Disorders
Palo Alto, California, United States
View Trial DetailsNCT Number: NCT00932932
The purpose of the study is to find out if people with Prader-Willi syndrome have a difference in the protein which changes inactive cortisone to the active stress hormone cortisol.
Looking for future studies?
Notify Me6 month and older
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MeChildren's Mercy Hospital Kansas City
Other
11 Beta Hydroxysteroid Dehydrogenase 1 (11-beta HSD 1) Activity in Patients With Prader-Willi Syndrome and in Healthy Controls
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05153434
Abnormalities, Multiple, Chromosome Disorders
Palo Alto, California, United States
View Trial DetailsNCT04257929
Abnormalities, Multiple, Chromosome Disorders
San Diego, California, United States
View Trial DetailsNCT02529085
Abnormalities, Multiple, Chromosome Disorders
Brussels, Belgium
View Trial DetailsNCT04697381
Abnormalities, Multiple, Chromosome Disorders
Yokohama, Kanagawa, Japan
View Trial Details